“High risk of secondary solid cancer after hematopoietic stem cell transplantation”
Patients who received allogeneic hematopoietic stem cell transplantation for a severe blood disease (hematologic cancer) such as leukemia have a higher risk of developing secondary solid cancer in solid organs than healthy people, a study has found. The research team at Catholic Blood Hospital, Seoul St. Mary’s Hospital, Catholic University of Korea, using data from … Read more